Ortho Development Corporation

Industry:	Medical Devices & Equipment
Revenues:	$21.7 Million
Employees:	49

Description

Ortho Development is the manufacturer of the devices described on this Site but does not practice medicine and does not recommend these surgical techniques or any other surgical techniques for use on a particular patient. The surgical techniques illustrated on this Site are used to demonstrate the surgical techniques as explained by a particular practicing surgeon referenced on the applicable web page. It is expected that a surgeon who performs any implant procedure is familiar with the fundamentals of implant procedures and is responsible for determining and utilizing the appropriate techniques for implanting a prosthesis in each individual patient. Ortho Development is not responsible for selection of the appropriate surgical technique to be utilized for an individual patient.

This Site may contain links to web sites not operated, controlled or in any way affiliated with Ortho Development but added to this Site only for your convenience. Ortho Development makes no warranty as to the accuracy, completeness; currency or reliability of the content available on these non-affiliated sites and shall not be liable for any damages or injury arising from users' access to such sites. Inclusion of any external link to a third party does not imply an endorsement or recommendation by Ortho Development.

Any communication or other material you send to Ortho Development, such as questions, comments, suggestions, is and will be deemed to be non-confidential and Ortho Development shall have no obligation of any kind with respect to such information. You agree that personally identifiable information voluntarily sent by you to e-mail addresses associated with this website will be deemed to be non-confidential information.

Ortho Development does not utilize unsolicited ideas for products or services. Please do not send any e-mail or in any other way communicate ideas for new products and services. Any e-mail containing unsolicited ideas may be deleted from our system immediately. By continuing to access this Site, and by submitting e-mail to us, you agree that you shall have no recourse against our company for any alleged or actual infringement or misappropriation of any proprietary rights in your communications to us.

You agree to indemnify, defend and hold harmless Ortho Development, its officers, directors, employees, agents, suppliers and third party partners from and against all losses, expenses, damages and costs, including reasonable attorneys' fees, resulting from any violation by you of these Terms of Use.

Any legal action or proceeding related to this Site shall be brought exclusively in a federal or state court in the State of Utah.

Ortho Development is a registered trademark of Ortho Development Corporation. The products, service marks, trade names, trade dress, and product names are either trademarks or registered trademarks of Ortho Development. Other product and company names mentioned herein may be trademarks, registered trademarks or trade names of their respective owners. Your accessing this Site should not be interpreted as granting, by implication or otherwise, any license or right to use any marks appearing on the Site without the prior written consent of Ortho Development or the owner thereof.

Products & Services

orthopedic implant devices, medical device

Find More Jobs

Job Openings

Product Development Engineer Draper , UT

View More Statistics

Site Statistics

Monthly Unique Visitors:	159
Site Rank:	3,709,262
Trust Rating:	Neutral
Stats by

News Archive

Research from A.P. Sanders and co-researchers in the area of manufacturing engineering described. Journal of Engineering; 7/8/2009 ...Transactions of the ASME, 2009;131(3):31001). For additional information, contact A.P. Sanders, Ortho Development Corp., 12187 S Business Pk Dr., Draper, UT 84020, USA. The publisher's contact information for the Journal... ...more

Metabolex's Multi-Part Deal With Ortho: $548M Potential. BIOWORLD Today; 11/3/2009 ...study of metaglidasen and the Phase I trial of MBX-2044, with clinical, regulatory and technical support from Ortho. Development costs for metaglidasen through the end of Phase II/III will be covered by Metabolex, and Ortho will pick up expenses... ...more